FDA
-
-
-
-
-
-
-
Aeterna Zentaris Provides Update on Timing for Annual Meeting of Shareholders and Due Bill Redemption Date
-
-
-
-
-
-
-
Aeterna Zentaris Reports Fourth Quarter and Full Year 2023 Financial Results and Announces Completion of Enrollment in Ongoing Pivotal DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone
-
-
-
-
-
-
-
Aeterna Zentaris to Present at the H.C. Wainwright 25th Annual Global Investment Conference
-
-
-
-
-
-
-
Aeterna Zentaris Announces Virtual 2023 Meeting of Shareholders
-
-
-
-
-
-
-
Aeterna Zentaris Provides Business Update and Outlines Key Upcoming Milestones
-
-
-
-
-
-
-
Aeterna Zentaris Reports Second Quarter 2022 Financial Results and Recent Highlights
-
-
-
-
-
-
-
Aeterna Zentaris Announces Shareholder Approval of Share Consolidation
-
323,573 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

